For specific groups, there probably is a kind of access problem. As for how big it is and the best way to solve this kind of problem—whether is it specifically related to access to pharmaceuticals or a more general problem—I would say that it's a political question. The reforms that I mentioned earlier when it comes to children, and young women when it comes to contraceptives, is one kind of response by the political system in adjusting the thresholds.
